CHROMIUM NICKEL OXIDE, GRANULAR, 0.85 TO 1.7MM, OEA

Hazard statements (CLP)

H317, H350i, H372, H413

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause cancer. Causes damage to organs through prolonged or repeated exposure. May cause an allergic skin reaction. May cause long lasting harmful effects to aquatic life

Hazard pictograms

GHS07 GHS08

Signal word

Danger

Contains

NICKEL MONOXIDE

Hazard statements

H317 - May cause an allergic skin reaction. H350i - May cause cancer by inhalation. H372 - Causes damage to organs through prolonged or repeated exposure. H413 - May cause long lasting harmful effects to aquatic life.

Precautionary statements

P201 - Obtain special instructions before use. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P308+P313 - IF exposed or concerned: Get medical advice/attention. P314 - Get medical advice/attention if you feel unwell. P321 - Specific treatment (see supplemental first aid instruction on this label).

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component CHROMIUM (III) OXIDE(1308-38-9) The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin sensitisation, Category 1 H317 Carcinogenicity (inhalation) Category 1A H350i Specific target organ toxicity – Repeated exposure, Category 1 H372 Hazardous to the aquatic environment – Chronic Hazard, Category 4 H413 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause cancer. Causes damage to organs through prolonged or repeated exposure. May cause an allergic skin reaction. May cause long lasting harmful effects to aquatic life.